Article

Similar pterygium outcomes regardless of surgeons’ level of expertise

Author(s):

Analysis finds acceptable outcomes can be expected when pterygium surgery is performed by a supervised ophthalmology resident.

Similar pterygium outcomes regardless of surgeons’ level of expertise

Pterygium recurrence rates were similar between attending physicians and supervised trainee residents.

John P. Thompson, MD, and colleagues from the Department of Ophthalmology, Louisiana State University at New Orleans, New Orleans, and the Department of Ophthalmology, University of Texas Health at San Antonio, San Antonio, reported that the experience level of the physicians performing pterygium does not impact the recurrence rate of the lesion, that is, the recurrences rates between attending physicians and supervised trainee residents were similar.

This retrospective analysis1 included primary pterygium surgeries that were performed by trainee residents and attending physicians in an academic institution in South Texas from 2008 to 2019. All residents who performed the surgeries were supervised directly by attending physicians. All patients had a minimal follow-up of 6 months postoperatively.

Pterygium results

A total of 240 eyes (229 patients; mean age, 55.6 ± 12.3 years; range, 28–91 years) were included. Attending physicians performed 100 surgeries that included 87 surgeries in which a conjunctival autograft was used and 13 surgeries in which an amniotic membrane graft was used. Trainee residents performed 140 surgeries that included 119 surgeries in which a conjunctival autograft was used and 21 surgeries in which an amniotic membrane graft was used.

The researchers reported that there were no significant differences between the 2 groups of patients regarding age, sex, and surgical technique. The average follow-up period was 19.8 ± 15.2 months.

In addition, the rates of recurrences of the pterygia did not differ between the experience levels of the surgeons when conjunctival autografts were used (6.8% vs. 10.0%, respectively, for attendings and trainees; p = 0.42) or when amniotic membrane grafts were used (69.2% vs. 47.6%, respectively; p = 0.22). Significant differences also were not found in other postoperative complications between the groups.

The study concluded, “Pterygium recurrence rates were similar between attending physicians and supervised trainee residents. Thus, acceptable outcomes can be expected when pterygium surgery is performed by a supervised ophthalmology resident.”

Reference
  1. Thompson JP, Harbin Z, Hrishikesh D, et al. Comparison of pterygium recurrence rates between attending physicians and supervised trainee residents. Cornea. 2022;41:12-15; doi: 10.1097/ICO.0000000000002721

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.